canceR agnOstic immUnoTherapy predIctioN blood-tEst

Project Information

ROUTINE

Grant agreement ID: 190109979

DOI

10.3030/190109979

Project closed

EC signature date 20 November 2023

Start date 1 August 2023

End date 31 July 2025

Funded under

• The European Innovation Council (EIC)

Total cost

€ 3 669 631,25

EU contribution

€ 2 500 000,00

Coordinated by

PAMGENE INTERNATIONAL BV
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Predicting response to immunotherapy in lung cancer: an early HTA of predictive tests

Author(s): Tim Govers, Evelien van Well, Rik De Wijn, Michel van den Heuvel
Published in: International Journal of Technology Assessment in Health Care, Issue 41, 2025, ISSN 0266-4623
Publisher: Cambridge University Press (CUP)
DOI: 10.1017/S0266462325100317

Intellectual Property Rights

Patent (7)

KINASE ACTIVITY SIGNATURES FOR PREDICTING THE RESPONSE OF NON-SMALL-CELL LUNG CARCINOMA PATIENTS TO A PD-1 OR PD-L1 IMMUNE CHECKPOINT INHIBITOR

Application/Publication number: 20 20074703
Date: 2020-09-04
Applicant(s): PAMGENE INTERNATIONAL BV

METHOD FOR PREDICTING THE RESPONSE OF NON-SMALL CELL LUNG CANCER PATIENTS TO TARGETED PHARMACOTHERAPY

Application/Publication number: 20 10054772
Date: 2010-04-12
Applicant(s): PAMGENE INTERNATIONAL BV

METHOD FOR PREDICTING THE RESPONSE OF MELANOMA PATIENTS TO A MEDICAMENT

Application/Publication number: 20 17057643
Date: 2017-03-31
Applicant(s): PAMGENE INTERNATIONAL BV

METHODS FOR PREDICTING THE RESPONSE OF A PATIENT TO TREATMENT WITH A PD-1 OR PD-L1 IMMUNE CHECKPOINT INHIBITOR

Application/Publication number: 20 21074319
Date: 2021-09-03
Applicant(s): PAMGENE INTERNATIONAL BV

MODIFIED TYROSINE AMINO ACIDS, PEPTIDES CONTAINING THEM, AND THEIR USE FOR DETECTING HYDROLASE ENZYME ACTIVITY

Application/Publication number: 20 12059293
Date: 2012-05-18
Applicant(s): PAMGENE INTERNATIONAL BV

METHOD FOR PREDICTING THE RESPONSE OF NON-SMALL-CELL LUNG CARCINOMA PATIENTS TO A MEDICAMENT

Application/Publication number: 20 18071569
Date: 2018-08-09
Applicant(s): PAMGENE INTERNATIONAL BV

METHOD FOR PREDICTING THE RESPONSE OF MELANOMA PATIENTS TO TARGETED PHARMACOTHERAPY

Application/Publication number: 20 16061361
Date: 2016-05-20
Applicant(s): PAMGENE INTERNATIONAL BV

Trademark (1)

IOpener trademark

Application/Publication number: BX 1406476
Date: 2019-11-22
Applicant(s): PAMGENE INTERNATIONAL BV